We are live on ! Find out more
SEM

Select Medical

Delisted

SEM was delisted on the 30th of June, 2026.

160 hedge funds and large institutions have $2.98B invested in Select Medical in 2014 Q4 according to their latest regulatory filings, with 21 funds opening new positions, 50 increasing their positions, 69 reducing their positions, and 27 closing their positions.

New
Increased
Maintained
Reduced
Closed

154% more capital invested

Capital invested by funds: $1.17B → $2.98B (+$1.81B)

149% more call options, than puts

Call options by funds: $1.04M | Put options by funds: $419K

3.43% more ownership

Funds ownership: 138.1%141.53% (+3.4%)

5% less funds holding

Funds holding: 168160 (-8)

22% less first-time investments, than exits

New positions opened: 21 | Existing positions closed: 27

25% less funds holding in top 10

Funds holding in top 10: 43 (-1)

28% less repeat investments, than reductions

Existing positions increased: 50 | Existing positions reduced: 69

Holders
160
Holders Change
-8
Holders Change %
-4.76%
% of All Funds
4.27%
Holding in Top 10
3
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-25%
% of All Funds
0.08%
New
21
Increased
50
Reduced
69
Closed
27
Calls
$1.04M
Puts
$419K
Net Calls
+$624K
Net Calls Change
+$330K
Name Holding Trade Value Shares
Change
Change in
Stake
MAA
26
Managed Account Advisors
New Jersey
$11M -$915K -125,462 -8%
RCM
27
Raptor Capital Management
Massachusetts
$10.9M -$1.96M -269,120 -16%
Geode Capital Management
28
Geode Capital Management
Massachusetts
$10.6M +$1.7M +233,589 +21%
RFC
29
Russell Frank Company
Washington
$9.58M -$2.03M -278,956 -19%
DVM
30
Dreman Value Management
Florida
$9.35M +$568K +77,811 +7%
Axa
31
Axa
France
$9.34M +$1.29M +177,433 +17%
Millennium Management
32
Millennium Management
New York
$9.22M +$624K +85,534 +8%
SGCIA
33
Smith Graham & Co Investment Advisors
Texas
$8.89M -$513K -70,379 -6%
BGIM
34
Brandywine Global Investment Management
Pennsylvania
$8.8M
PI
35
Putnam Investments
Massachusetts
$8.38M +$2.43M +332,814 +45%
MACM
36
March Altus Capital Management
Connecticut
$7.83M -$2.09M -287,126 -22%
D.E. Shaw & Co
37
D.E. Shaw & Co
New York
$7.8M -$684K -93,773 -9%
TA
38
Teachers Advisors
New York
$7.59M -$4.33K -594 -0.1%
RA
39
Royce & Associates
New York
$7.17M -$2.61M -357,280 -28%
State of Wisconsin Investment Board
40
State of Wisconsin Investment Board
Wisconsin
$7.15M
AQR Capital Management
41
AQR Capital Management
Connecticut
$7.06M +$1.32M +180,309 +25%
EA
42
Emerald Advisers
Pennsylvania
$6.75M -$515K -70,660 -8%
Morgan Stanley
43
Morgan Stanley
New York
$6.36M -$3.4M -466,320 -36%
Prudential Financial
44
Prudential Financial
New Jersey
$6.03M -$1.01M -137,901 -15%
PPA
45
Parametric Portfolio Associates
Washington
$5.83M +$1.95M +267,871 +55%
Wells Fargo
46
Wells Fargo
California
$5.53M -$482K -66,113 -8%
DCM
47
Decade Capital Management
New York
$5.48M +$377K +51,716 +8%
AP
48
AHL Partners
United Kingdom
$5.47M +$890K +121,976 +21%
Two Sigma Advisers
49
Two Sigma Advisers
New York
$5.21M -$1.47M -202,118 -23%
GC
50
Guggenheim Capital
Illinois
$5.17M +$4.69M +643,321 +2,823%

SEM Hedge Fund Activity: Q4 2014 in Review

160 of the 3,751 institutional investors tracked by Wall St. Rank reported a position in Select Medical (SEM) for Q4 2014, worth a combined $2.98B — up 154% from $1.17B a quarter earlier.

Sellers outnumbered buyers: 27 funds closed out of SEM and 21 opened new positions — a net loss of 6 holders — while 69 trimmed existing stakes and 50 added.

The largest buyer was Comerica Bank, adding an estimated $28.5M. The largest seller was Boston Partners, cutting an estimated $17.4M.

  • 160 institutional investors held Select Medical (SEM) as of Q4 2014, down from 168 in Q3 2014.
  • Funds reported $2.98B of Select Medical stock for Q4 2014, up 154% quarter-over-quarter.
  • 21 funds opened new Select Medical positions in Q4 2014 and 27 closed out, a net change of -6 holders.
  • The largest Select Medical buyer in Q4 2014 was Comerica Bank, an estimated $28.5M added.
  • The largest Select Medical seller in Q4 2014 was Boston Partners, an estimated $17.4M sold.

Based on aggregated 13F filings for Q4 2014.